You are here: Home > Institute of Excellence (CPD) > CPD Events > SCO CPD for Optometrists

SCO CPD for Optometrists

Date: 16/03/2021 (AEST)

Venue: Ocean Room/ Peppers Noosa Resort, 33A Viewland Drive Noosa Heads , QLD, 4567

Provider: SUNSHINE COAST OPHTHALMOLOGISTS AT NOOSA

Contact: ANNA OCYSEK, [E] optom@sconoosa.com.au, [P] 0419899524

Learning Objectives

  • At the completion of the CPD activity (1 above), participants should be able to understand Plaquenil protocols with regard to maculopathy, determine the total cumulative dose of Plaquenil and the dangers associated with exceeding this with regard to maculopathy. The participant should be able to better understand the use of OCT and VFT examinations to screen for early maculopathy and referral pathways if necessary for its management.
  • At the completion of the CPD activity (2 above) the participant should be able to understand the difference between the various Anti-VegF treatments available on the market and the efficacy of each. The participant should be able to counsel patients with macular disease on the treatment options available to them accordingly.
  • At the completion of the CPD activity (3 above) the participant should better understand diabetic eye disease and referral pathways. The participant should be able to gain new knowledge on current strategies for treatment of diabetic macular oedema, and proliferative diabetic retinopathy, including pros and cons of anti vegF treatments, dexamethasone implants and PRP in treatment of DMO. The participant should be able to counsel patients on the various treatment options available.

Max CPD hours awarded: 1.5

Session Information

Name
Plaquenil- Protocols and Pitfalls
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
CNVM and ARMD - Review of current anti-vegF treatments
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Diabetic Eye Disease Refresher
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5